Search for: "Watson Laboratories" Results 141 - 160 of 250
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jul 2011, 9:59 pm by Patent Docs
• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
22 Jun 2011, 4:09 am by Marie Louise
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]
13 Jun 2011, 1:58 pm
Laboratory tests showed Watson’s blood alcohol level was 0.07, below the state’s 0.08 limit (and the Southern California DUI limit of 0.08% BAC). [read post]
13 Jun 2011, 1:57 pm by uwlegalscholarship
The Journal of Law: A Periodical Laboratory of Legal Scholarship, Vol. 1, No. 1, pp. 1-10, 2011; George Mason Law & Economics Research Paper No. 11-15. [read post]
9 Jun 2011, 10:16 am
Indianapolis, IN - Patent lawyers for Alcon Research Ltd of Fort Worth, Texas, Alcon Pharmaceuticals LTD of Switzerland, and Kyowa Haddo Kirin Co. of Japan filed a patent infringement in alleging Watson Laboratories Inc and Watson Pharma, Inc. of Parsippany, New Jersey, and Watson Laboratories, of Corona, California, infringed the following patent prior to the expiration: Patent No. 5,641,805, Topical ophthalmic formulations for treating allergic eye… [read post]
1 May 2011, 8:45 pm by Patent Docs
• Defendants: Watson Pharmaceuticals Inc.; Watson Pharma Inc.; Watson Laboratories Inc. [read post]
25 Apr 2011, 8:51 am by Keith Lee
Of course, new frontiers are not limited to the ivory tower and the laboratory. [read post]
12 Apr 2011, 9:37 pm by Patent Docs
• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
28 Mar 2011, 9:59 pm by Patent Docs
Watson Laboratories, Inc., the Federal Circuit reversed a decision by the District Court for the District of Nevada on summary judgment that the asserted claims of U.S. [read post]
27 Mar 2011, 9:28 pm by Patent Docs
Watson Laboratories, Inc. [read post]
25 Mar 2011, 8:29 pm
Watson Laboratories (CAFC 2010-1331) insensibly nonprecedential Preliminaries to clobbering '969. [read post]
21 Mar 2011, 2:04 pm by Tom Lamb
And, thereafter, we will likely see: (1) Teva Pharmaceuticals and Barr Laboratories make an identical label change for Ocella, a generic version of Yasmin, as well as Gianvi, a generic version of YAZ; and, (2) Watson Pharmaceuticals do likewise for Zarah, another generic version of Yasmin. [read post]
15 Mar 2011, 6:29 am by Larry Ribstein
Watson is an early sighting of a highly disruptive force. [read post]
25 Feb 2011, 7:12 am by Phil
(collectively "Shire") have received a new Paragraph IV Notice Letter from Watson Laboratories, Inc. in Fort Lauderdale, Florida ("Watson") advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of all approved strengths of Shire's ADDERALL XR(R) (mixed salts of a single-entity amphetamine product) dextroamphetamine sulphate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, amphetamine… [read post]
31 Jan 2011, 6:50 pm by Editors
Check out these featured jobs courtesy of GoInhouse.com: Counsel – Confidential, Bergen County, NJ Associate General Counsel – eHealthInsurance, Mountain View, CA Attorney – Pacific Northwest National Laboratory, Richland, WA Counsel – Towers Watson, Washington, DC (New York, Philadelphia, Arlingto) Counsel – Towers Watson, New York, NY (Philadelphia, Arlingto) Compliance Counsel – Confidential, New York, NY (Midtown Manhattan)… [read post]
25 Jan 2011, 10:58 pm by Marie Louise
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
19 Jan 2011, 2:44 pm by Phil
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]